ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "M05B" (83)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Alendronic Acid (M05BA04) 12 products WHO-DDD  
  IPCI Fosamax 70 mg - T4 Tablet(s)17.7635.6510 %Tablets: Acidum Alendronicum 70 mgOrganon GmbHB / SL / SOG
  IPCI Fosamax 70 mg - T12 Tablet(s)51.1171.8010 %Tablets: Acidum Alendronicum 70 mgOrganon GmbHB / SL / SOG
  IPCI Alendronat Sandoz 70416.1934.0510 %Coated tablets: Acidum Alendronicum 70 mgSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Alendronat Sandoz 701246.6067.2010 %Coated tablets: Acidum Alendronicum 70 mgSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Alendronat Spirig HC 70 mg4 Tablet(s)16.1934.0510 %Tablets: Acidum Alendronicum 70 mgSpirig HealthCare AGB / SL / SGG
  IPCI Alendronat Spirig HC 70 mg12 Tablet(s)46.6067.2010 %Tablets: Acidum Alendronicum 70 mgSpirig HealthCare AGB / SL / SGG
  IPCI Alendron-Mepha 70 mg4 Tablet(s)16.1734.0510 %Filmtablette: Acidum Alendronicum 70 mgMepha Pharma AGB / SL / SGG
  IPCI Alendron-Mepha 70 mg12 Tablet(s)46.6067.2010 %Filmtablette: Acidum Alendronicum 70 mgMepha Pharma AGB / SL / SGG
  IPCI Binosto 70 mg4 Tablet(s)17.4235.3010 %Comprimés effervescents: Acidum Alendronicum 70 mgEffRx Pharmaceuticals SAB / SLG
  IPCI Binosto 70 mg1244.4364.9510 %Comprimés effervescents: Acidum Alendronicum 70 mgEffRx Pharmaceuticals SAB / SLG
  IPCI Alendronat-Mepha4k.A.Tablets: Acidum Alendronicum 70 mgMepha Pharma AGBG
  IPCI Alendronat-Mepha12k.A.Tablets: Acidum Alendronicum 70 mgMepha Pharma AGBG
Ibandronic Acid (M05BA06) 16 products WHO-DDD  
L IPCI Bonviva i.v.syringe(s)49.0169.4020 %Injection solution: Acidum Ibandronicum 3mg / 3mlAtnahs Pharma
Switzerland AG
B / SL / SOG
L IPCI Bonviva 150 mgITablet(s)17.0635.0010 %Coated tablets: Acidum Ibandronicum 150 mgAtnahs Pharma
Switzerland AG
B / SL / SOG
L IPCI Bonviva 150 mgI3 Tablet(s)46.5767.2510 %Coated tablets: Acidum Ibandronicum 150 mgAtnahs Pharma
Switzerland AG
B / SL / SOG
L IP  Ibandronat Sandoz i.v.syringe(s)44.1164.3510 %Injection solution: Acidum Ibandronicum 3mg / 3mlSandoz
Pharmaceuticals AG
B / SL / SGG
L IP  Ibandronat Spirig HC i.v. 3
mg/3 ml
Fertigspritze(n)44.1164.3510 %Injection solution: Acidum Ibandronicum 3mg / 3mlSpirig HealthCare AGB / SL / SGG
L IP  Ibandronat-Mepha Osteo
i.v. 3 mg/ 3 ml
Fertigspritze(n)42.3562.5510 %Injection solution in prefilled syringe: Acidum Ibandronicum 3 mgMepha Pharma AGB / SL / SGG
L IPCI Ibandronat Sandoz 150Tablet(s)14.4332.3010 %Coated tablets: Acidum Ibandronicum 150 mgSandoz
Pharmaceuticals AG
● B / SL / SGG
L IPCI Ibandronat Sandoz 1503 Tablet(s)41.9162.5010 %Coated tablets: Acidum Ibandronicum 150 mgSandoz
Pharmaceuticals AG
● B / SL / SGG
L IPCICMIbandronat Spirig HC 150 mg
Monatstabletten
 14.4332.3010 %Coated tablets: Acidum Ibandronicum 150 mgSpirig HealthCare AGB / SL / SGG
L IPCICMIbandronat Spirig HC 150 mg
Monatstabletten
341.9162.5010 %Coated tablets: Acidum Ibandronicum 150 mgSpirig HealthCare AG● B / SL / SGG
L IPCI Ibandronat-Mepha 150 mg
Monatstabletten
 14.4332.3010 %Coated tablets: Acidum Ibandronicum 150 mgMepha Pharma AG● B / SL / SGG
L IPCI Ibandronat-Mepha 150 mg
Monatstabletten
341.9162.5010 %Coated tablets: Acidum Ibandronicum 150 mgMepha Pharma AG● B / SL / SGG
L IPCI Bondronat 6 mg/6 mlDurchstechflasche(n)178.71210.7510 %Concentrate for infusion: Acidum Ibandronicum 6mg / 6mlAtnahs Pharma
Switzerland AG
B / SLG
  IP  Ibandronat Zentiva Osteo 44.1164.35k.A.Injection solution: Acidum Ibandronicum 3mg / 3mlHelvepharm AGBG
     Bonames FilmtablettenTablet(s)k.A.Recordati AGBG
     Bonames Filmtabletten3 Tablet(s)k.A.Recordati AGBG
Risedronic Acid (M05BA07) 5 products WHO-DDD DrugBank.ca 
L IPCI Actonel 35 mg
hebdomadaires
4 Tablet(s)15.4433.2010 %Coated tablets: Natrii Risedronas 35 mgLabatec Pharma SAB / SLG
L IPCI Actonel 35 mg
hebdomadaires
12 Tablet(s)43.5363.7510 %Coated tablets: Natrii Risedronas 35 mgLabatec Pharma SAB / SLG
  IPCI Actonel 35 mg415.4433.2010 %comprimés gastro-résistants: Natrii Risedronas 35 mgLabatec Pharma SAB / SLG
  IPCI Actonel 35 mg1243.5363.7510 %comprimés gastro-résistants: Natrii Risedronas 35 mgLabatec Pharma SAB / SLG
  IPCI Actonel 30 mg28 Tablet(s)241.96294.15k.A.Coated tablets: Natrii Risedronas 30 mgLabatec Pharma SABG
Zoledronic Acid (M05BA08) 15 products WHO-DDD  
L IP  AclastaDurchstechflasche(n) à 100 ml219.40254.4520 %Infusion solution: Acidum Zoledronicum 5mg / 100mlSandoz
Pharmaceuticals AG
B / SL / SOG
  IP  Zoledronat Onco Labatec, 4
mg/100 ml
100 ml108.31134.1010 %Infusion solution: Acidum Zoledronicum 4mg / 100mlLabatec Pharma SAB / SL / SGG
L IP  Zoledronat OSTEO Labatec 186.49220.6510 %Infusion solution: Acidum Zoledronicum 5mg / 100mlLabatec Pharma SAB / SL / SGG
L IP CMZoledronat Osteo Sandoz 5
mg/100 ml
Durchstechflasche(n)186.49220.6510 %Infusion solution: Acidum Zoledronicum 5mg / 100mlSandoz
Pharmaceuticals AG
B / SL / SGG
L IP  Zoledronat Osteo Spirig HC 5
mg/100 ml
 186.49220.6510 %Infusion solution: Acidum Zoledronicum 5mg / 100mlSpirig HealthCare AGB / SL / SGG
  IP  Zoledronsäure Onco Sandoz 4 mg / 100 ml100 ml108.31134.1010 %Infusion solution: Acidum Zoledronicum 4mg / 100mlSandoz
Pharmaceuticals AG
B / SL / SGG
  IP  Zoledronat Accord onco 4
mg/5 ml
 105.85131.5510 %Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlAccord Healthcare AGB / SL / SGG
  IP  Zoledronat Fresenius Onco 4
mg/5 ml
Durchstechflasche(n)98.47124.0010 %Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlFresenius Kabi
(Schweiz) AG
B / SL / SGG
  IP  Zoledronat Onco Labatec 4
mg/5 ml
Durchstechflasche(n)108.31134.1010 %Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlLabatec Pharma SAB / SL / SGG
  IP  Zoledronat-Teva onco 4 mg/ 5 ml 108.31134.1010 %Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlTeva Pharma AGB / SL / SGG
  IP CMZoledronsäure Onco Sandoz 4
mg/5 ml
Durchstechflasche(n)108.31134.1010 %Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Zometa 4 mg/5 mlDurchstechflasche(n)165.83193.10k.A.Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlNovartis Pharma
Schweiz AG
BG
    CMZoledronat osteo Aspen 5
mg/100 ml
100 mlk.A.Infusion solution: Acidum Zoledronicum 5mg / 100mlIpsen Pharma Schweiz
GmbH
G
  IP  Eotriz 4 mg/5 ml k.A.Concentrate for infusion: Acidum Zoledronicum 4mg / 5mlSciClone
Pharmaceuticals
Switzerland GmbH
BG
  IP  Zoledronat-Acino Osteo 5mgDurchstechflasche(n)k.A.Infusion solution: Acidum Zoledronicum 5mg / 100mlAcino Pharma AGBG
Alendronic Acid and Colecalciferol (M05BB03) 4 products WHO-DDD DrugBank.ca 
L IPCI Fosavance 70/280012 Tablet(s)35.9455.5010 %Weekly tablets: 2 Active AgentsOrganon GmbHB / SL / SOG
L IPCI Fosavance 70/560012 Tablet(s)35.9455.5010 %Weekly tablets: 2 Active AgentsOrganon GmbHB / SL / SOG
  IPCI Fosavance 70/28004 Tablet(s)12.4930.00k.A.Weekly tablets: 2 Active AgentsOrganon GmbHBG
  IPCI Fosavance 70/56004 Tablet(s)12.4930.00k.A.Weekly tablets: 2 Active AgentsOrganon GmbHBG
Dibotermin Alfa (M05BC01) 2 products WHO-DDD DrugBank.ca 
 SIPIP  InductOs 1.5 mg/ml,
poudre 12 mg
Set(s)k.A.solvant et matrice pour matrice pour implantation: Diboterminum Alfa 12 mgMedtronic BioPharma
Sàrl
BG
 SIPIP  InductOs 1.5 mg/ml,
poudre 4 mg
 k.A.solvant et matrice pour matrice pour implantation: Diboterminum Alfa 4 mgMedtronic BioPharma
Sàrl
BG
Aluminium Chlorohydrate (M05BX02) 1 products WHO-DDD  
L IPCI Phosphonorm100 Capsule(s)31.9751.2010 %Capsules: Aluminii Chloridum/hydroxidum Hydricum (9:8:19:23) 300 mgSalmon Pharma GmbHB / SLG
Denosumab (M05BX04) 19 products WHO-DDD DrugBank.ca 
  IP  Denosumab-Mepha osteo 60
mg/ml
 10 %Mepha Pharma AGB / SLG
  IP  Denosumab-Teva onco 120 mg / 1.7 ml 10 %Teva Pharma AGA / SLG
L IP  Osenvelt 120 mg/1.7 ml (70
mg/ml)
 172.04210.4510 %Injection solution: Denosumabum 120mg / 1.7mliQone Healthcare
Switzerland SA
A / SLG
L IP  Wyost 120 mg/ 1.7 ml 172.04210.4510 %Injection solution: Denosumabum 120 mgSandoz
Pharmaceuticals AG
A / SLG
L IP  XGEVA 120 mgDurchstechflasche(n)229.39269.3010 %Injection solution: Denosumabum 120mg / 1.7mlAmgen Switzerland AGA / SLG
L IPCI Jubbonti 60 mg/ml 174.42206.1010 %Injection solution in prefilled syringe: Denosumabum 60 mgSandoz
Pharmaceuticals AG
B / SLG
L IPCI XGEVA 120 mg/1 ml 229.39269.3010 %Injection solution in prefilled syringe: Denosumabum 120 mgAmgen Switzerland AGA / SLG
L IPCI Proliasyringe(s)191.86224.0010 %Injektionslösung in Fertigspritze mit Nadelschutz: Denosumabum 60 mg/mlAmgen Switzerland AGB / SLG
L IPCI Stoboclo 60 mg 174.42206.1010 %solution injectable en seringue préremplie: Denosumabum 60 mg/mliQone Healthcare
Switzerland SA
B / SLG
  IPCI Denosumab-Mepha osteo,
Injektionslösung in einer
Fertigspritze
 174.42206.1010 %Mepha Pharma AGG
  IP  Denosumab-Teva onco,
Injektionslösung
 k.A.Teva Pharma AGG
  IP  Denosumab-Teva onco,
Injektionslösung
 172.04210.4510 %Teva Pharma AGG
  IP  Denosumab-Teva onco 120 mg / 1.7 ml3k.A.Teva Pharma AGAG
     Vevzuo 120 mg/1.7 ml (70
mg/ml)
 k.A.Injection solution: Denosumabum 120mg / 1.7mlMedius AGAG
     Evfraxy 60 mg/ml k.A.Injection solution in prefilled syringe: Denosumabum 60 mg/mlMedius AGBG
  IP  Xbryk 120 mg/1.7 ml k.A.Injection solution: Denosumabum 120mg / 1.7mlSamsung Bioepis CH
GmbH
AG
  IP  XGEVA 120 mg4 Durchstechflasche(n)k.A.Injection solution: Denosumabum 120mg / 1.7mlAmgen Switzerland AGAG
  IPCI Obodence k.A.Injection solution in prefilled syringe: Denosumabum 60 mg/mlSamsung Bioepis CH
GmbH
BG
     Denosumab Zentiva 60 mg k.A.Injektionslösung (s.c.): Denosumabum 60 mgHelvepharm AGBG
Burosumab (M05BX05) 3 products WHO-DDD  
  IP  Crysvita 10 mg/1 ml k.A.Injection solution: Burosumabum 10 mg/mlKyowa Kirin SàrlBG
  IP  Crysvita 20 mg/1 ml k.A.Injection solution: Burosumabum 20 mg/mlKyowa Kirin SàrlBG
  IP  Crysvita 30 mg/1 ml k.A.Injection solution: Burosumabum 30 mg/mlKyowa Kirin SàrlBG
Romosozumab (M05BX06) 1 products WHO-DDD  
L IPCI Evenity 105 mg/1.17 ml2439.49494.4010 %Injection solution in prefilled syringe: Romosozumabum 105mg / 1.17mlUCB-Pharma SAB / SLG
Vosoritide (M05BX07) 3 products WHO-DDD  
  IPCI Voxzogo 0.4 mg10k.A.Lyophilisate and solvent: VosoritidumDRAC AGAG
  IPCI Voxzogo 0.56 mg10k.A.Lyophilisate and solvent: VosoritidumDRAC AGAG
  IPCI Voxzogo 1.2 mg10k.A.Lyophilisate and solvent: Vosoritidum 1.2 mgDRAC AGAG
Sonstige die Knochenmineralisation beeinflussende Pharmaka (Diverse) (M05BX99) 1 products WHO-DDD DrugBank.ca 
   CIAWeleda Aufbaukalk 1+2 k.A.Pulver zum Einnehmen: 2 Active Agents
Pulver zum Einnehmen: 3 Active Agents
Weleda AGDG
(M05BZ) 1 products WHO-DDD  
   CIHDr. Reckeweg R 34
Calcossin
50 mlk.A.Drops: 5 Active AgentsLaboratoire Jacques
Reboh et fils SA
DG
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home